ORIENT BIO Market Cap

ORIENT BIO has a market cap or net worth of 197.42 billion as of March 28, 2025. Its market cap has increased by 186.08% in one year.

Market Cap

197.42B

Enterprise Value

n/a

Revenue

59.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,855.00

Market Cap Chart

Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 197.42B, an increase of 532.74%. That is a compound annual growth rate of 6.43%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	197.42B	7.63%
Dec 30, 2024	183.42B	154.86%
Dec 28, 2023	71.97B	-0.98%
Dec 29, 2022	72.68B	-49.75%
Dec 30, 2021	144.65B	-3.55%
Dec 30, 2020	149.97B	116.58%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,844.44B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings